Subsequently, we also found that the phosphorylation of IκBα, an upstream regulatory molecule of NF-κB pathway, was inhibited in ESCC cells after ivermectin treatment (Fig. 4A and B). Here, NFKB1 is linked to esophageal squamous cell carcinoma.